Crossmark

Development and Optimization of Stability-Indicating Method of Solifenacin Succinate and its Main Product of Degradation in Tablet Dosage form using the Quality by Design Approach

Crossref DOI link: https://doi.org/10.1134/S1061934824030055

Published Online: 2024-02-26

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cabral, Raphael Cyriaco

Lourenço, Felipe Rebello

Calixto, Leandro Augusto
License Information

Text and Data Mining valid from 2023-12-01

Version of Record valid from 2023-12-01
More Information

Article History

Received: 1 April 2023

Revised: 5 August 2023

Accepted: 4 September 2023

First Online: 26 February 2024

CONFLICT OF INTEREST

: The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below